AN OPEN-LABEL CLINICAL STUDY ON THE EFFICACY OF GODANTI BHASMA WITH PATHYADI KWATHA IN THE MANAGEMENT OF ARDHAVABHEDAKA (MIGRAINE)

Introduction: Migraine is a primary headache disorder characterized by recurrent attacks of a specific type of pain in one half of the head. The prevalence of Migraine in India is found to be around 26%. Migraine has a significant negative impact on sufferers' ability to work, engage in social activities, and maintain a family life. Patients who are treated with contemporary medicine have undesirable side effects or are hesitant to take medication and do not react to conventional therapy. According to Ayurvedic classics, signs and symptoms of Ardhavabhedaka (a type of Shiroroga) can be correlated with Migraine. Considering the limited availability of conventional medicine treatment options, this study was conducted. Godanti bhasma is used in various types of headaches, whereas Pathyadi Kwatha is indicated in the management of Shiroroga. Objective: To evaluate the efficacy of Godanti bhasma with Pathyadi kwatha in the management of Ardhavabhedaka (Migraine). Materials and Methods: It is an open-label single-arm clinical study. Setting: Shreeyash Ayurved Hosp., Chh. Sambhajinagar. 20 diagnosed patients of migraine were randomly selected from OPD & IPD. The selected subjects were administered Shamana Therapy, comprising Godanti Bhasma (125 mg) and Pathyadi Kwatha (15 ml), twice a day after meals, for 60 days. Discussion: Based on the assessment criteria, the data were graded, and the results were analyzed statistically. Results: The outcome of the treatment was found to be statistically significant in 20 patients after 2 months of the treatment.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-12-01
DOI
https://doi.org/10.5281/zenodo.18220615
Primary Topic
Medical Case Reports and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AN OPEN-LABEL CLINICAL STUDY ON THE EFFICACY OF GODANTI BHASMA WITH PATHYADI KWATHA IN THE MANAGEMENT OF ARDHAVABHEDAKA (MIGRAINE)

Dr. Kavita Kishor Fadnavis2 Dr. Paresh Rameshrao Deshmukh*1
Zenodo (CERN European Organization for Nuclear Research)
Medical Case Reports and Studies
article

AN OPEN-LABEL CLINICAL STUDY ON THE EFFICACY OF GODANTI BHASMA WITH PATHYADI KWATHA IN THE MANAGEMENT OF ARDHAVABHEDAKA (MIGRAINE)

Dr. Kavita Kishor Fadnavis2 Dr. Paresh Rameshrao Deshmukh*1
article en

Abstract

Introduction: Migraine is a primary headache disorder characterized by recurrent attacks of a specific type of pain in one half of the head. The prevalence of Migraine in India is found to be around 26%. Migraine has a significant negative impact on sufferers' ability to work, engage in social activities, and maintain a family life. Patients who are treated with contemporary medicine have undesirable side effects or are hesitant to take medication and do not react to conventional therapy. According to Ayurvedic classics, signs and symptoms of Ardhavabhedaka (a type of Shiroroga) can be correlated with Migraine. Considering the limited availability of conventional medicine treatment options, this study was conducted. Godanti bhasma is used in various types of headaches, whereas Pathyadi Kwatha is indicated in the management of Shiroroga. Objective: To evaluate the efficacy of Godanti bhasma with Pathyadi kwatha in the management of Ardhavabhedaka (Migraine). Materials and Methods: It is an open-label single-arm clinical study. Setting: Shreeyash Ayurved Hosp., Chh. Sambhajinagar. 20 diagnosed patients of migraine were randomly selected from OPD & IPD. The selected subjects were administered Shamana Therapy, comprising Godanti Bhasma (125 mg) and Pathyadi Kwatha (15 ml), twice a day after meals, for 60 days. Discussion: Based on the assessment criteria, the data were graded, and the results were analyzed statistically. Results: The outcome of the treatment was found to be statistically significant in 20 patients after 2 months of the treatment.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 24%
Medical Case Reports and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

AN OPEN-LABEL CLINICAL STUDY ON THE EFFICACY OF GODANTI BHASMA WITH PATHYADI KWATHA IN THE MANAGEMENT OF ARDHAVABHEDAKA (MIGRAINE) — Dr. Kavita Kishor Fadnavis2 Dr. Paresh Rameshrao Deshmukh*1 · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS